Clinical standardization of two controlled allergen challenge facilities
Anne K. Ellis(Queen's University), Cynthia Rather(Biogen (United States)), Robert L. Jacobs(Biogen (United States)), Cynthia M. Visness(Rho (United States)), Daniel Ramirez(Biogen (United States)), Mark W. Tenn(Queen's University), Alkis Togias(National Institute of Allergy and Infectious Diseases), Daniel E. Adams, Lisa M. Steacy(Kingston General Hospital), Terry J. Walker(Kingston General Hospital), Robert L. James(Rho (United States)), Charles P. Andrews(Biogen (United States))
Cited by 12
Related Papers
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision
|Journal of Allergy and Clinical Immunology|2017|2k
Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children
|New England Journal of Medicine|2011|870
Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma
|Journal of Allergy and Clinical Immunology|2010|746
Anaphylaxis—a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis
|Journal of Allergy and Clinical Immunology|2020|690
Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs
|Journal of Allergy and Clinical Immunology|2012|642